Anandakrishnan Nandakumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anandakrishnan Nandakumar has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Dipu Thareparambil Sathyapalan
Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, India
3 shared publications - Georg Gutjahr
Amrita Vishwa Vidyapeetham
3 shared publications - Aryalakshmi Sreemohan
Clinical Research Division, The Liver Institute, Center of Excellence in Gastrointestinal Sciences, Rajagiri Hospital, Aluva 683112, Kerala, India
2 shared publications - Merlin Moni
Division of Infectious Diseases, Amrita Institute of Medical Sciences, Kochi, Kerala, India
2 shared publications - Rahul Krishnan Pathinarupothi
Center for Wireless Networks Applications (WNA), Amrita Vishwa Vidyapeetham, Amritapuri, Kollam, India
2 shared publications - Sashi Niranjan Nair
Division of Infectious Diseases Department of Medicine University of Minnesota Medical School Minneapolis Minnesota USA
2 shared publications
Latest Publications
- 15 March 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 189, 109979
AI Enhanced explainable early prediction of blood culture positivity in neutropenic patients using clinical and hematologic parameters
- 15 March 2025
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 189, 109979
AI Enhanced explainable early prediction of blood culture positivity in neutropenic patients using clinical and hematologic parameters
- Open Access
- 30 September 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (10) , 935-941
Developing Augmented Pro-SOFA and Pro-SAPS Models by Integrating Biomarkers PCT, NLR, and CRP with SOFA and SAPS-III Scores
Background: Sepsis, a life-threatening condition characterized by a dysregulated immune response to infection, remains a significant clinical challenge globally. This study aims to enhance the predictive accuracy of existing sepsis severity scores by developing augmented versions of the SOFA and SAPS-III models, termed Pro-SOFA and Pro-SAPS, through the integration of biomarkers procalcitonin (PCT), neutrophil-tolymphocyte ratio (NLR), and C-reactive protein (CRP). Methods: This prospective observational study was conducted in the medical ICU of a tertiary care hospital in southern India from August 2022 to December 2023. A total of 301 adult patients suspected or confirmed to have sepsis were assessed for eligibility, with 171 patients completing the study. Demographic and clinical data were collected; SOFA and SAPS-III scores were calculated and augmented with PCT, NLR, and CRP to develop Pro-SOFA and Pro-SAPS models. The performance of these models was evaluated using Brier scores, AUC, and net reclassification index (NRI). Results: The augmented Pro-SOFA and Pro-SAPS models demonstrated superior predictive accuracy compared to their original counterparts. The Brier scores for Pro-SOFA and Pro-SAPS were 0.181 and 0.165, respectively, indicating better calibration than the original scores. The Pro- SAPS showed significant improvement over the original SAPS-III score (NRI = 0.50, SE = 0.14, p < 0.01). Similarly, Pro-SOFA outperformed the original SOFA (NRI = 0.49, SE = 0.13, p < 0.01). Conclusion and clinical significance: Integrating PCT, CRP, and NLR with SOFA and SAPS-III scores to develop Pro-SOFA and Pro-SAPS significantly improves the predictive accuracy for sepsis mortality and can thus potentially improve sepsis outcomes.
- 30 September 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (10) , 935-941
Open AccessDeveloping Augmented Pro-SOFA and Pro-SAPS Models by Integrating Biomarkers PCT, NLR, and CRP with SOFA and SAPS-III Scores
Background: Sepsis, a life-threatening condition characterized by a dysregulated immune response to infection, remains a significant clinical challenge globally. This study aims to enhance the predictive accuracy of existing sepsis severity scores by developing augmented versions of the SOFA and SAPS-III models, termed Pro-SOFA and Pro-SAPS, through the integration of biomarkers procalcitonin (PCT), neutrophil-tolymphocyte ratio (NLR), and C-reactive protein (CRP). Methods: This prospective observational study was conducted in the medical ICU of a tertiary care hospital in southern India from August 2022 to December 2023. A total of 301 adult patients suspected or confirmed to have sepsis were assessed for eligibility, with 171 patients completing the study. Demographic and clinical data were collected; SOFA and SAPS-III scores were calculated and augmented with PCT, NLR, and CRP to develop Pro-SOFA and Pro-SAPS models. The performance of these models was evaluated using Brier scores, AUC, and net reclassification index (NRI). Results: The augmented Pro-SOFA and Pro-SAPS models demonstrated superior predictive accuracy compared to their original counterparts. The Brier scores for Pro-SOFA and Pro-SAPS were 0.181 and 0.165, respectively, indicating better calibration than the original scores. The Pro- SAPS showed significant improvement over the original SAPS-III score (NRI = 0.50, SE = 0.14, p < 0.01). Similarly, Pro-SOFA outperformed the original SOFA (NRI = 0.49, SE = 0.13, p < 0.01). Conclusion and clinical significance: Integrating PCT, CRP, and NLR with SOFA and SAPS-III scores to develop Pro-SOFA and Pro-SAPS significantly improves the predictive accuracy for sepsis mortality and can thus potentially improve sepsis outcomes.
- 1 September 2016
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (9) , 1853-1863
Diagnostic accuracy of tests for diabetic foot osteomyelitis: a Bayesian network meta-analysis protocol
Objective: The objective of this systematic review is to evaluate and compare the diagnostic accuracy of physical examination, foot imaging, and inflammatory marker tests for the diagnosis of diabetic foot osteomyelitis in adults. Introduction: Diabetic foot osteomyelitis is a serious complication of diabetic foot ulcers, often leading to amputation, prolonged hospitalization, and increased mortality. Several diagnostic modalities, ranging from bedside examinations to advanced imaging and laboratory biomarkers, are available; however, their diagnostic performance varies widely in terms of accuracy, invasiveness, and cost. Eligibility criteria: This review will include diagnostic accuracy studies evaluating adults with diabetes and suspected diabetic foot osteomyelitis, comparing index tests (clinical, lab, imaging) against a reference standard (biopsy or clinical follow-up). Eligible studies must clearly define diabetic foot osteomyelitis as a diagnostic outcome and specify which criteria are used to the confirm the diagnosis. Methods: A 3-step search strategy will be applied. We will search Cochrane Central, Scopus, MEDLINE, ProQuest, and OAISTER. Google Scholar and ProQuest will be searched for gray literature. Studies published from January 2000 to the present will be considered. Two reviewers will independently conduct title and abstract screening, retrieval of full-text studies, full-text review, study selection, data extraction, and risk of bias assessment. Estimates of the individual results will be visualized by coupled forest plots, and the variability of individual results will be visualized using cross-hairs plots. For each index test, a random-effects, bivariate beta-binomial model will be used to pool sensitivity and specificity. Heterogeneity will be assessed using Zhou and Dendukuri’s bivariate extension of the I2 statistic. Publication bias will be investigated using Deeks’ funnel plots. Sensitivity and subgroup analyses will be performed. For subgroups of index tests that form networks, we will perform diagnostic test accuracy network meta-analysis using a random-effects, bivariate beta-binomial arm-based model. The certainty of evidence for each diagnostic comparison will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for diagnostic test accuracy. Review registration: PROSPERO CRD420251085609
- 1 September 2016
- Published by Wolters Kluwer Health in JBI Evidence Synthesis
- Vol. 24 (9) , 1853-1863
Diagnostic accuracy of tests for diabetic foot osteomyelitis: a Bayesian network meta-analysis protocol
Objective: The objective of this systematic review is to evaluate and compare the diagnostic accuracy of physical examination, foot imaging, and inflammatory marker tests for the diagnosis of diabetic foot osteomyelitis in adults. Introduction: Diabetic foot osteomyelitis is a serious complication of diabetic foot ulcers, often leading to amputation, prolonged hospitalization, and increased mortality. Several diagnostic modalities, ranging from bedside examinations to advanced imaging and laboratory biomarkers, are available; however, their diagnostic performance varies widely in terms of accuracy, invasiveness, and cost. Eligibility criteria: This review will include diagnostic accuracy studies evaluating adults with diabetes and suspected diabetic foot osteomyelitis, comparing index tests (clinical, lab, imaging) against a reference standard (biopsy or clinical follow-up). Eligible studies must clearly define diabetic foot osteomyelitis as a diagnostic outcome and specify which criteria are used to the confirm the diagnosis. Methods: A 3-step search strategy will be applied. We will search Cochrane Central, Scopus, MEDLINE, ProQuest, and OAISTER. Google Scholar and ProQuest will be searched for gray literature. Studies published from January 2000 to the present will be considered. Two reviewers will independently conduct title and abstract screening, retrieval of full-text studies, full-text review, study selection, data extraction, and risk of bias assessment. Estimates of the individual results will be visualized by coupled forest plots, and the variability of individual results will be visualized using cross-hairs plots. For each index test, a random-effects, bivariate beta-binomial model will be used to pool sensitivity and specificity. Heterogeneity will be assessed using Zhou and Dendukuri’s bivariate extension of the I2 statistic. Publication bias will be investigated using Deeks’ funnel plots. Sensitivity and subgroup analyses will be performed. For subgroups of index tests that form networks, we will perform diagnostic test accuracy network meta-analysis using a random-effects, bivariate beta-binomial arm-based model. The certainty of evidence for each diagnostic comparison will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for diagnostic test accuracy. Review registration: PROSPERO CRD420251085609